Cytodyn Inc (CYDY)

[dadbrotheroftwins]

FDA's decision not to include 4 doses for CD12 trial is what prompted many longs to petition FDA. I know that you feel that longs are "pestering" and their concerns for unfairness are putting the chance of approval from US FDA at risk, but I ask you, if the trial was approached with the same method as Remdesivir where they had the flexibility to change end points and dosing, do you really believe that leronlimab would not prove superior? Every other country and WHO are all calling for an end to treatment with Remdesivir, yet the US continues to use this drug. So since it appears that leronlimab was treated unfairly, do you honestly believe that the approach by many doctors and members of this board can cause any more harm. FDA has shown that they are corrupt imo, not only from the design of the CD12 trial where 4 doses was not allowed, but from the timing of the pr that was put out during market hours. If you believe otherwise, then you have a short interest to satisfy imo and are unworthy of any further conversation.